These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide].
    Author: Kato D, Achiwa H, Sato S, Bessho Y, Shimizu S, Hattori N, Maeda H, Niimi T, Oguri T, Ueda R.
    Journal: Gan To Kagaku Ryoho; 2005 Mar; 32(3):377-9. PubMed ID: 15791821.
    Abstract:
    We described a case of thymic carcinoma that responded remarkably to combined chemotherapy with etoposide (ETP), ifosfamide (IFO) and nedaplatin. A 68-year-old woman was admitted to our hospital because of hoarseness and dysphasia. Chest computed tomographic (CT) scans showed an anterior mediastinal tumor. Using CT-guided needle biopsy, the diagnosis was squamous cell type of thymic carcinoma. We gave her modified VIP therapy with ETP, IFO and nedaplatin. The tumor contraction response was evident after 3 courses of treatment. This case suggested that nedaplatin may be one of the promising agents for thymic carcinoma chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]